Equity · Healthcare
HROW
NASDAQHarrow (HROW)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 1.8B USD
- Revenue, year to Dec 2025
- 272.3M USD
- EPS, diluted, year to Dec 2025
- −0.14 USD
- 52-week range
- 29 USD – 55 USD
- Avg volume
- 125.9K
as of Jul 17, 2026
Have Harrow (HROW) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Harrow insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 18 May 2026.
Form 4, 90 days to 10 Nov 2026, newest reported trade 14 Aug 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Aug 2026 | Shojaei AmirCHIEF SCIENTIFIC OFFICER | Sell | 11,250 | 450K USD |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Aug 2026 | Shojaei AmirCHIEF SCIENTIFIC OFFICER | Option exercise | 11,250 | 405K USD |
Which funds hold Harrow (HROW)?
6 of the 45 institutional funds we track reported a Harrow position for the quarter ended 30 Jun 2026 — a combined 37.9M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Marshall Wace | Trimmed | 369,435 | 15.7M USD | −42.7% |
| Citadel Advisors | Added | 359,874 | 15.3M USD | +62.6% |
| Millennium Management | New position | 84,182 | 3.6M USD | |
| Renaissance Technologies | Trimmed | 44,617 | 1.9M USD | −47.2% |
| Two Sigma Investments | New position | 22,476 | 955K USD | |
| Tudor Investment Corp | New position | 11,480 | 488K USD | |
| AQR Capital Management | Exited |
What has been filed or recorded for Harrow (HROW)?
The filings we hold for Harrow, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 4,911 shares | 139K USD notional · 0.013% of shares out |
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 72,090 shares | 2.1M USD notional · 0.192% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 52,796 shares | 1.6M USD notional · 0.141% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 54,715 shares | 1.7M USD notional · 0.146% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 37,178 shares | 1.1M USD notional · 0.099% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,315 shares | 41K USD notional · 0.004% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.25 USD | |
| 30 Sep 2026 | Financials | Total assets | 443.0M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 29.2M USD | at period end |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 82 shares | 3K USD notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.46 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.74 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.14 USD | |
| 31 Dec 2025 | Financials | Revenue | 272.3M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −5.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.14 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.03 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.13 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.50 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −0.49 USD |
What do people ask about Harrow (HROW)?
What is Harrow’s market cap?1.8B
Harrow is worth 1.8B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Harrow’s revenue?272.3M
Harrow reported revenue of 272.3M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Harrow insiders bought or sold shares recently?1 sale
In the 90 days to 10 Nov 2026, Harrow insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 18 May 2026. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own Harrow?6 of 45
6 of the 45 funds we track reported a Harrow position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace, Citadel Advisors and Millennium Management. See Funds
When did Harrow last report earnings?0.25
Harrow last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.25 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings